IL-37 exerts direct anti-inflammatory action and blocks nuclear factor kappa B (NF-κB) and mitogen-activated protein kinase (MAPK), reducing tumor growth, angiogenesis, and metastasis. This evidence concerns the gene IL37 and neoplasm.